Sage Therapeutics, Inc.
- UEI
- MLVRGDVJSWY3
- CAGE
- 6DBP9
- SAM.gov registration
- Deleted
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- supernus.com
- Founded
- 2005
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Neuroactive steroid gabaa receptor positive modulators for fragile x syndrome | National Institutes of Health | $225,040 |
Quick answers
Is Sage Therapeutics, Inc. registered in SAM.gov?
Sage Therapeutics, Inc.'s SAM.gov registration was deleted on April 8, 2016.
Which contract vehicles does Sage Therapeutics, Inc. hold?
Sage Therapeutics, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Sage Therapeutics, Inc.'s most recent federal award?
Sage Therapeutics, Inc.'s most recent federal grant award is Neuroactive steroid gabaa receptor positive modulators for fragile x syndrome (U01NS083605), from National Institutes of Health, on October 28, 2013.
On GovTribe
See Sage Therapeutics, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors